logo

For the Inventor, By the Inventor

Daejeon, South Korea

Yong Z Kim

This inventor holds 10 USPTO granted patents. Top assignee: Lucky Limited. Active years: 1990-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yong Z Kim. Retrieved from https://idiyas.com/inventor/yong-z-kim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 100.0

Average Co-Inventor Count = 6.2

ph-index = 3

Forward Citations = 34(Granted Patents)


Location History:

  • Doryong, KR (1992)
  • Daejeon-Si, KR (1990 - 1993)
  • Youseong-ku, KR (1996)
  • Daejeon, KR (1994 - 1997)

Company Filing History:

goldMedal10 out of 76 
 
Lucky Limited
 patents

Years Active: 1990-1997

Loading Chart...
10 patents (USPTO):Explore Patents
1. 5605895 - Cephalosporin antibiotics and processes for preparation thereof (1997-02-25),
2. 5571804 - Cephalosporin antibiotics (1996-11-05),
3. 5541175 - Cephalosporin antibiotics (1996-07-30),
4. 5462935 - Cephalosporin compounds (1995-10-31),
5. 5416081 - Cephalosporin compounds (1995-05-16),
6. 5292733 - Cephalosporin compounds (1994-03-08),
7. 5202315 - Cephalosporin compounds (1993-04-13),
8. 5189202 - Process for the preparation of 3,3-dimethyl-4-pentenoic acid (1993-02-23),
9. 5142041 - Cephalosporin intermediates (1992-08-25),
10. 4971962 - Cephalosporin compounds (1990-11-20),

Title: Yong Z Kim: Innovator in Cephalosporin Antibiotics

Introduction

Yong Z Kim is a distinguished inventor based in Daejeon, South Korea, known for his significant contributions in the field of pharmaceuticals with a particular focus on cephalosporin antibiotics. With a total of ten patents to his name, his work is pivotal to advancements in antibiotic therapies.

Latest Patents

Among his latest innovations, Yong Z Kim has developed cephalosporin antibiotics that involve novel compounds represented by specific chemical formulas. These compounds not only provide a foundation for generation of new antibiotic agents but are also safe and effective in their application. The latest patents encapsulate both the cephalosporin compound and the processes for their preparation, aimed at improving the efficacy of antibiotic treatments.

Career Highlights

Throughout his career, Yong Z Kim has demonstrated an unparalleled commitment to research and development in medicine. His work has led to the creation of groundbreaking antibiotics that enhance treatment options for bacterial infections, which is critical in an era of increasing antibiotic resistance.

Collaborations

Yong Z Kim has collaborated with notable colleagues, including Jae H Yeo and Jong Chan Lim, contributing to a dynamic team effort that has furthered research initiatives at Lucky Limited. Their joint efforts have propelled advances in pharmaceutical innovations, making significant impacts in public health.

Conclusion

Yong Z Kim's work exemplifies the essence of innovation in medicine, particularly in the realm of antibiotics. His dedication to improving healthcare through his patented inventions is a testament to the importance of continued research and development in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…